Klaus Hellmann, DVM, is the Head of Europe CRO at Argenta, bringing extensive expertise in animal health product development. He has played a pivotal role in securing successful marketing authorisations for numerous products across various organisations.
Klaus studied veterinary medicine at the University of Veterinary Medicine Hannover in Germany. His career began at Pfizer in Germany, where he gained invaluable experience before founding Klifovet in 1997. As CEO of Klifovet until its acquisition by Argenta in May 2022, Klaus led the company to become the leading animal health CRO in Europe.
Klaus remains actively involved in several animal health and veterinary organisations, including the Association of Veterinary Consultants (AVC), the European College for Veterinary Pharmacology and Toxicology, AAVP, AAVPT, and WAAVP.
